Pharmacelera
PrivateLast Round
VC Round
Feb 18, 2026
Est. Valuation
$10.18M
Total Funding Raised
$5.24M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pharmacelera is a healthcare technology company that develops and provides computer-aided drug design (CADD) software and services applying quantum mechanics and artificial intelligence for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmacelera Comparables
Compare Pharmacelera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSolveIT | 86% | |
| Chemical Computing Group | 81% | |
| BEIT | 81% |
Pharmacelera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 18, 2026 | ||||
| Grant | Dec 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| Crowdfunding | Jan 31, 2023 | ||||
| Crowdfunding | May 1, 2021 | ||||
Grant | May 19, 2020 |
Key People
Founding team and executive leadership
Pharmacelera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noso Capital | VC Round |
| European Innovation Council Fund | Grant |
| Ministerio de Economía, Comercio y Empresa | Grant |
| Inveready | VC Round |
| European Commission | Grant |
| European Regional Development Fund | Grant |
| HERAN Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 6, representing 21% of headcount.
- May 3, 2026
Grew 17% QoQ, from 24 to 28 employees.
Pharmacelera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharmacelera's valuation, stock price, and market status.
Is Pharmacelera a public or private company?
Pharmacelera is a private company.
What is the current stock price of Pharmacelera?
Pharmacelera is a private company with no public stock price. No recent secondary market data is available.
How much is Pharmacelera worth (valuation)?
Pharmacelera's valuation is estimated at $10.2M based on funding round data.
Can I buy Pharmacelera stock?
Pharmacelera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pharmacelera's last funding round?
Pharmacelera's most recent funding round was VC Round on January 31, 2023.
Who are the main investors in Pharmacelera?
Key investors in Pharmacelera include HERAN Partners, General Inception.
Will Pharmacelera IPO soon?
No public IPO plans have been announced for Pharmacelera.
How can I track Pharmacelera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharmacelera's secondary market activity and sign up for updates.